Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
Ann Surg ; 276(5): 860-867, 2022 11 01.
Article in English | MEDLINE | ID: mdl-35894428

ABSTRACT

OBJECTIVE: To define benchmark cutoffs for redo liver transplantation (redo-LT). BACKGROUND: In the era of organ shortage, redo-LT is frequently discussed in terms of expected poor outcome and wasteful resources. However, there is a lack of benchmark data to reliably evaluate outcomes after redo-LT. METHODS: We collected data on redo-LT between January 2010 and December 2018 from 22 high-volume transplant centers. Benchmark cases were defined as recipients with model of end stage liver disease (MELD) score ≤25, absence of portal vein thrombosis, no mechanical ventilation at the time of surgery, receiving a graft from a donor after brain death. Also, high-urgent priority and early redo-LT including those for primary nonfunction (PNF) or hepatic artery thrombosis were excluded. Benchmark cutoffs were derived from the 75th percentile of the medians of all benchmark centers. RESULTS: Of 1110 redo-LT, 373 (34%) cases qualified as benchmark cases. Among these cases, the rate of postoperative complications until discharge was 76%, and increased up to 87% at 1-year, respectively. One-year overall survival rate was excellent with 90%. Benchmark cutoffs included Comprehensive Complication Index CCI ® at 1-year of ≤72, and in-hospital and 1-year mortality rates of ≤13% and ≤15%, respectively. In contrast, patients who received a redo-LT for PNF showed worse outcomes with some values dramatically outside the redo-LT benchmarks. CONCLUSION: This study shows that redo-LT achieves good outcome when looking at benchmark scenarios. However, this figure changes in high-risk redo-LT, as for example in PNF. This analysis objectifies for the first-time results and efforts for redo-LT and can serve as a basis for discussion about the use of scarce resources.


Subject(s)
End Stage Liver Disease , Liver Transplantation , Tissue and Organ Procurement , Benchmarking , End Stage Liver Disease/surgery , Graft Survival , Humans , Retrospective Studies , Treatment Outcome
2.
J Laparoendosc Adv Surg Tech A ; 32(10): 1032-1037, 2022 Oct.
Article in English | MEDLINE | ID: mdl-35446126

ABSTRACT

Background: Laparoscopic technique has been increasingly applied in the treatment of selected pancreatic tumors. The aim of this study is to evaluate the experience with laparoscopic enucleation of pancreatic neoplasms (LEPNs), for selected pancreatic diseases, at a high-volume referral center. Methods: Between May 2012 and October 2020, LEPNs was attempted in 16 patients with selected pancreatic neoplasms. The localization of tumors, etiology, indications, and clinical outcomes were analyzed. Results: Sixteen patients were included. LEPN was successfully performed in 13 patients, 3 conversions to open procedure were required. The definitive histopathological result of the resected pieces showed prevalence of intraductal papillary mucinous neoplasms. Postoperative major complications occurred for 3 patients (18.7%), the 3 of them presented postoperative pancreatic fistula (POPF). The median hospital stay was 4.5 days (range 2-7) for patients without POPF and 14.6 days (3-30) for those who presented with POPF. No deaths were registered. During a median follow-up of 43.8 months (0.2-109), no new-onset exocrine or endocrine insufficiency was diagnosed, no patient experienced tumor recurrence and, the 4 patients who underwent LEPN for insulinoma, remained asymptomatic. Conclusion: LEPNs has become a valuable alternative for patients with benign or low risk of malignancy tumors. Appropriate preoperative imaging is key for localization. Whenever feasible, this technique not only reduces the risks of exocrine and endocrine insufficiency, but also adds the well-known advantages of minimally invasive techniques, making it a safe and feasible treatment.


Subject(s)
Laparoscopy , Pancreatic Neoplasms , Humans , Laparoscopy/methods , Neoplasm Recurrence, Local/surgery , Pancreatectomy/methods , Pancreatic Fistula/etiology , Pancreatic Neoplasms/diagnosis , Postoperative Complications/etiology , Retrospective Studies , Treatment Outcome
3.
Iran J Otorhinolaryngol ; 34(123): 199-204, 2022 Jul.
Article in English | MEDLINE | ID: mdl-36035645

ABSTRACT

Introduction: Carotid body tumors (CBTs) are certainly unusual. They are vascular lesions originating from paraganglionic cells, located at the common carotid artery (CCA) bifurcation. They represent less than 0.5% of head and neck tumors, approximately 1-3 cases per million. Malignant CBTs are extremely rare; in the literature, published rates on average are < 10%. The diagnostic criteria for malignancy should be based on the finding of distant metastasis. Due to its unpredictable nature and its malignant potential, diagnosis before metastasis and complete surgical resection are the keys to a favorable prognosis. Case Report: Given little experience in CBTs, its biology and treatment remain uncertain. We present the case of a 48-years-old patient, with a mass on the left side of the neck that was found to be a vast CBT with suspicious histopathology. Its size, rare location, pathologic findings, and management strategy applied for its treatment, illustrate an unusual case that highlights the importance of its publication. Conclusions: CBT is rare, but subject to cure lesion if resected without metastatic or residual disease. This is why surgery should be performed whenever possible and why it is so necessary to study this pathology thoroughly and to take it into account in the differential diagnosis.

4.
Cardiovasc Intervent Radiol ; 45(3): 330-336, 2022 Mar.
Article in English | MEDLINE | ID: mdl-34796374

ABSTRACT

PURPOSE: The aim of this study was to report the long-term results of an institutional protocol of percutaneous biliary balloon dilatation (PBBD) on paediatric patients with benign anastomotic stricture after liver transplantation. As a secondary objective, we evaluated risk factors associated with post-treatment re-stricture. MATERIALS AND METHODS: Fourteen paediatric, post-liver transplant patients with benign anastomotic stricture of Roux-en-Y hepaticojejunostomy were included. All patients underwent the same treatment protocol of three PBBD procedures with 15-day intervals. Clinical outcome was analysed using the Terblanche classification. Primary patency rate was assessed with the Kaplan-Meier test. RESULTS: All patients had an initial successful result (Terblanche grade, excellent/good) after PBBD. At the end of the follow-up time of 35.7 ± 21.1 months (CI95%, 23.5-47.9), 10 patients persisted with excellent/good grading, while the remaining 4 had re-stricture, all of the latter occurring within the first 19 months. Patency rate after percutaneous treatment at 1, 3, and 5 years were 85.7%, 70%, and 70%, respectively. History of major complication after liver transplantation was associated with 5 times higher risk of re-stricture, HR 5.48 [95% CI, 2.18-8.78], p = 0.018. CONCLUSION: In paediatric patients with benign anastomotic stricture of hepaticojejunostomy after liver transplantation, the "Three-session" percutaneous biliary balloon dilatation protocol is associated with a high rate of long-term success. In this limited series, the history of post-liver transplant major complication, defined as complications requiring a reintervention under general anaesthesia or advanced life support, seems to be an independent risk factor for stricture recurrence.


Subject(s)
Liver Transplantation , Child , Constriction, Pathologic/surgery , Dilatation/methods , Humans , Liver Transplantation/adverse effects , Postoperative Complications/diagnostic imaging , Postoperative Complications/etiology , Postoperative Complications/therapy , Retrospective Studies , Treatment Outcome
5.
Rev Fac Cien Med Univ Nac Cordoba ; 78(2): 184-187, 2021 06 28.
Article in Spanish | MEDLINE | ID: mdl-34181846

ABSTRACT

Squamous cell carcinoma of the tongue is the most common malignant tumor of the oral cavity. The finding of metastases, in this type of cancer, is considered the main factor of poor prognosis with a marked effect on the overall survival. The normal progression tends to be locoregional, at the surgical site or regional lymph nodes, and systemic involvement is usually uncommon. We present the case of a male patient, 40 years old, with tongue cancer and bilateral kidney metastases, eleven months after initial diagnosis. The aggressive biology, the extremely rare metastases location and a grim prognosis, illustrate an unusual case, which highlights the importance of its publication.


El carcinoma escamoso de lengua es la lesión maligna más frecuente de la cavidad oral. El hallazgo de metástasis en este tipo de neoplasias se considera el principal factor de mal pronóstico con efecto marcado en la sobrevida global del paciente. La progresión habitual suele ser locorregional, en el lecho quirúrgico o a nivel ganglionar, siendo poco frecuente el hallazgo de afectación sistémica.  Se presenta el caso de un paciente masculino de 40 años de edad con diagnóstico de cáncer de lengua y metástasis renales bilaterales, a los 11 meses del diagnóstico inicial. La biología agresiva, la localización extremadamente rara de las metástasis y el pronóstico sombrío ilustran un caso inusual que resalta la importancia de su publicación.


Subject(s)
Carcinoma, Squamous Cell , Humans , Retrospective Studies , Tongue
SELECTION OF CITATIONS
SEARCH DETAIL